IVF and genetic testing
Understand how embryo testing fits into an IVF pathway, what may affect the timeline and which questions deserve a case-specific answer.
A clearer decision path
Understand how embryo testing fits into an IVF pathway, what may affect the timeline and which questions deserve a case-specific answer.
PGT-A, PGT-M and PGT-SR are different testing pathways. The appropriate discussion depends on the patient history, genetic information, embryo availability and how a result could affect a clinical decision.
An IVF with PGT pathway may include stimulation, retrieval, IVF or ICSI, embryo culture, biopsy, vitrification, laboratory analysis and a later frozen embryo transfer. Not every retrieved egg becomes an embryo suitable for biopsy, and no test guarantees a future outcome.
Ask how biopsy, testing, embryo number, transport between laboratories, freezing, storage, genetic counselling, repeat or inconclusive testing and a later transfer are quoted.
Before consent, ask which result categories may be reported, who explains them and how clinic policy treats mosaic, inconclusive or no-result embryos. Complex decisions may require genetic counselling.
Connect the proposed test to a specific question, not a generic package.
Know where biopsy and testing occur and how results are reported.
Discuss limitations, alternatives and possible result categories before testing.
Next step
Prepare a concise case summary, then compare case-specific clinical proposals rather than relying on general package claims.